<DOC>
	<DOCNO>NCT01335217</DOCNO>
	<brief_summary>This 20-subject , dose find study examine use external trigeminal nerve stimulation ( TNS ) adjunctive treatment adult major depressive disorder ( MDD ) co- occur posttraumatic stress disorder ( PTSD ) add onto antidepressant medication . Our primary objective examination TNS patient population . To accomplish specific aim , investigator test follow specific hypothesis : 1 . Subjects show improvement rating mood , PTSD , symptoms eight-week period . 2 . Subjects show improvement rating life functional capacity quality life TNS . 3 . Subjects report TNS treatments acceptable term side effect burden use device .</brief_summary>
	<brief_title>Trigeminal Nerve Stimulation Post Traumatic Stress Disorder ( PTSD ) Depression</brief_title>
	<detailed_description>A total 20 subject Major Depressive Disorder ( MDD ) co-occurring Post Traumatic Stress Disorder ( PTSD ) , age 18 75 year , consent join project UCLA . The project use TNS open-label condition , use stimulation parameter use prior study MDD treatment-refractory epilepsy . Subjects see every two week 8 week study . At end 8 week , TNS system return adjunctive treatment end . The co-primary endpoint change depression severity PTSD severity enrollment week 8 visit .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<criteria>Inclusion Criteria 1 . Outpatients nonpsychotic , unipolar Major Depressive Disorder AND Posttraumatic Stress Disorder , assess via MINI structure interview 2 . A score ≥ 14 HAMD17 Item 1 ( depressed mood ) ≥ 2 3 . A score ≥ 50 CAPS ( ClinicalAdministered PTSD Scale DSMIV ) 4 . A history treatment failure least one adequate trial antidepressant previous 6 week , change antidepressant medication dose within previous 6 week , ongoing use least one antidepressant ( continue participation study ) 5 . Age range : 18 75 . 6 ) Patients suicidal ideation eligible thought death life worth live accompanied plan intention selfharm . Exclusion Criteria 1 . Patient mentally legally incapacitate , unable give inform consent . 2 . Patients psychosis ( psychotic depression , schizophrenia , schizoaffective diagnosis ( lifetime ) ) ; bipolar disorder ( lifetime ) ; dementia ( lifetime ) ; delirium substance abuse disorder within past 6 month ; eat disorder within past year ; obsessive compulsive disorder ( lifetime ) ; acute risk suicide selfinjurious behavior . Patients diagnostic uncertainty ambiguity ( e.g . ruleout pseudodementia depression ) exclude . 3 . Patients exposure ECT VNS within past 6 month . 4 . Past history skull fracture ; cranial surgery enter calvarium ; space occupy intracranial lesion ; stroke , CVA , TIAs ; cerebral aneurysm ; Parkinson 's Huntington 's disease ; Multiple Sclerosis . 5. current pregnancy , breast feeding , plan become pregnant 12week treatment phase study , use medically accept mean contraception . 6 . Other medical contraindication study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder ( MDD )</keyword>
	<keyword>Trigeminal Nerve Stimulation</keyword>
	<keyword>Post Traumatic Stress Disorder</keyword>
</DOC>